000			01827nam a22002417a 4500
008			130108t2009 vau||||| |||| 00| 0 eng d
022			_a1932-5037
082			_221 _a050/K83
085			_aAI 050/K83
089			_221 _aAI 050/K83
100			_aKollipara, Sobha.
245			_aDiabetes technologies and their role in diabetes management/
246			_aAmerican Journal of Health Education.
300			_a2 figs.; 2 tables; refs.
362			_avol. 40, no. 5 (September/October 2009): 292-297.
520			_aThe 1993 Diabetes Complications and Control Trial (DCCT) showed that controlling blood glucose prevents and delays the progression of long term complications of diabetes. New diabetes technologies can make control of diabetes possible and safer. This paper reviews these technologies used to monitor blood glucose, administer insulin and evaluate effectiveness of therapy. Self-monitoring of blood glucose has been a standard of care for several decades. Today, patients and practitioners can gain great benefit from data that can be provided by using Continuous Glucose Monitoring (CGM). Current physiologic insulin therapy regimens have improved blood glucose control capabilities. Insulin therapy devices; including pens and pumps are reviewed. Advantages of insulin pump therapy and features of the latest 'smart' pumps are described. Children with diabetes, and their families, have many challenges as well as many opportunities to employ new technologies in diabetes management plans. The ability of school and care givers to support children can impact the overall success of any diabetes therapy regimen.
650			_a DIABETES.
700			_aSilverstein, Janet H.
700			_aMarschilok, Katie.
942			_2ddc _cPER
999			_c2584 _d2584
040			_cLearning Resource Center